Erlotinib intermediates manufacturer
Product Description
Crizotinib (trade name Xalkori, Pfizer) is an anti-cancer drug acting as an ALK (anaplastic lymphoma kinase) and ROS1 (c-ros oncogene 1) inhibitor, approved for treatment of some non-small cell lung carcinoma (NSCLC) in the US and some other countries, and undergoing clinical trials testing its safety and efficacy in anaplastic large cell lymphoma, neuroblastoma, and other advanced solid tumors in both adults and children.
Function and Application
Crizotinib is an active pharmaceutical ingredient used for antineoplastics.
Specification
Name: Crizotinib |
||
CAS No.: |
877399-52-5 |
|
Content: |
98.5-101.5% |
|
Appearance: |
White Crystalline Powder |
|
Formula: |
C21H22Cl2FN5O |
|
Molecular Weight |
450.3367 |
|
Moisture: |
≤0.1% |
|
Loss on Drying: |
≤0.2% |
|
Residue on ignition: |
≤0.1% |
|
Density: |
1.475g/cm3 |
|
Boiling point: |
599.177°C at 760 mmHg |
|
Flash(ing) point: |
316.171°C |
|
Heavy Metals: |
≤10PPM |
|
Acidity or Alkalinity: |
Conform |
|
Chloride: |
Conform |
|
Readily Carbonizable Substances: |
Conform |
|
Ordinary Impurities: |
Conform |
|
Packing and Storage
1kg with double plastic container inside/Aluminum foil bag ;
25kg with double plastic container inside/Fiber drum outside.Or as your request.
Shipped in 3 days after payment.
1.Stored in a cool and dry well-closed container and in ventilated area.
2.kept away from moisture and strong light or high temperature.
3.Two years under well storage situation and stored away from direct sun light.
